Report Summary
China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.


I. INTRODUCTION
    Report Scope and Methodology
    Executive Summary
II. BUSINESS ENVIRONMENT
    Economic Outlook
    Key Economic Indicators
    Industrial Output
    Population and Labor
    Foreign Investment
    Foreign Trade
    Financial and Tax Regulations
    Banking System and Regulations
    Foreign Exchange
    Taxes, Tariff and Custom Duties
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
    Blood Disease Drugs Industry Structure
    Market Size
    Market Growth Drivers
    Blood Disease Drugs Sales Volume
    Major Producer Facility Locations and Sales Volume
    Market Share of Key Producers
    Labor Cost
    Potential Entrants
    Major Distributors
    Major Foreign Investment
    Technology Development
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
    Overview
    Demand of Blood Disease Drugs by Region
    Blood Disease Drugs Sales Volume
    Anemia Treatment Drugs
    Mecobalamin
    Cobamamide
    Ferrous Succinate
    Leucogen
    Neutropenia and Agranulocytosis Treatment Drugs
    VitamineB4
    Batilol
    Inosine
    Deoxyribonucleotide
    Adrenocortical Hormone
    Granulocyte Colony-Stimulating Factor(G-CSF)
    Leukemia Treatment Drugs Sales Volume
    Interferon
    Imatinib
    Rituximab
    Pirarubicin
    Hydroxycampothecin
    Other Blood Disease Drugs Sales Volume
    Blood Disease Drugs Imports
    Anemia Treatment Drugs
    Mecobalamin
    Cobamamide
    Ferrous Succinate
    Leucogen
    Neutropenia and Agranulocytosis Treatment Drugs Imports
    VitamineB4
    Batilol
    Inosine
    Deoxyribonucleotide
    Adrenocortical Hormone
    Granulocyte Colony-Stimulating Factor(G-CSF)
    Leukemia Treatment Drugs Imports
    Interferon
    Imatinib
    Rituximab
    Pirarubicin
    Hydroxycampothecin
    Other Blood Disease Drugs Imports
    Pricing Trends
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
    Blood Disease Drugs Market Outlook Overview
    Government Regulation
    Health Care Insurance Industry Overview
    Consumer Spending Trends
    Demographic Trends
    Health Care Industry Trends
    Hospitals and Hospital Beds
    Physicians and Physician Visits
VI. MARKETING STRATEGIES
    China Market Entry Overview
    China’s Distribution System
    Special Rubber Distribution Channels
    Transportation and Freight Infrastructure
    Communications
    China’s Market Entry
    Export to China
    Indirect export
    Direct Export
    License and Contract Manufacture
    Assembling in China
    Contract Manufacturing
    Trade Permit
    Investment
    Equity Joint Venture
    Contractual Joint Venture
    Wholly Foreign-Owned Enterprise
VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY
    Blood Disease Drugs Producer Profiles
    Distributors and Trading Companies
    Research Institutions and Associations
LIST OF TABLES
I. INTRODUCTION

    Economic Outlook Summary
II. BUSINESS ENVIRONMENT
    Key Economic Indicators
    Industrial Output
    Population and Labor Force Trends
    Foreign Investment and Loans
    Foreign Trade
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
    Anemia Treatment Drugs Sales Volume by Drugs Classification
    Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
    Leukemia Treatment Drugs Sales Volume by Drugs Classification
    Blood Disease Drugs Sales Volume
    Major Producer Facility Location
    Major Blood Disease Drugs Producer Sales Volume
    Market Share of Key Producers
    Major Foreign Investment in China
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
    Total Blood Disease Drugs Sales Volume
    Blood Disease Drugs Major Producer and Their Market Share
    Anemia Major Producer and Their Market Share
    Anemia Treatment Drugs Sales Volume by Drugs Classification
    Anemia Treatment Drugs Major Producer and Their Market Share
    Mecobalamin Major Producer and Their Market Share
    Cobamamide Major Producer and Their Market Share
    Ferrous Succinate Major Producer and Their Market Share
    Leucogen Major Producer and Their Market Share
    Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
    Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
    VitamineB4 Major Producer and Their Market Share
    Batilol Major Producer and Their Market Share
    Inosine Major Producer and Their Market Share
    Deoxyribonucleotide Major Producer and Their Market Share
    Adrenocortical Hormone Major Producer and Their Market Share
    Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
    Leukemia Treatment Drugs Major Producer and Their Market Share
    Leukemia Treatment Drugs Sales Volume by Drugs Classification
    Interferon Major Producers and Their Market Share
    Imatinib Mesylate Major Producer and Their Market Share
    Rituximab Major Producer and Their Market Share
    Pirarubicin Major Producer and Their Market Share
    Hydroxycampothecin Major Producer and Their Market Share
    Blood Disease Drugs Import
    Anemia Treatment Drugs Import Volume by Drugs Classification
    Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
    Leukemia Treatment Drugs Import Volume by Drugs Classification
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
    Consumer Spending Trend
    Demographic Trends
    Health Care Industry Trends
    Hospitals and Hospital Beds
    Physicians and Physician Visits
LIST OF CHARTS
I. NTRODUCTION

    Blood Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT
    China's GDP and Industrial Output
    Industrial Output by Ownership
    China’s Imports and Exports
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
    Anemia Treatment Drugs Sales Volume by Drugs Classification in 2008
    Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification in 2008
    Leukemia Treatment Drugs Sales Volume by Drugs Classification
    Blood Disease Drugs Sales Volume
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
    Blood Disease Drugs Sales Volume
    Worldwide Blood Disease Drugs Demand by region
    Anemia Major Producer and Their Market Share
    Anemia Treatment Drugs Sales Volume by Drugs Classification
    Mecobalamin Sales Volume and Market Share
    Cobamamide Sales Volume and Market Share
    Ferrous Succinate Sales Volume and Market Share
    Leucogen Sales Volume and Market Share
    Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
    Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification in 2008
    VitamineB4 Sales Volume and Market Share
    Batilol Sales Volume and Market Share
    Inosine Sales Volume and Market Share

Posted by a on
categories:

Subscribe via email

Enter your email address:

Delivered by FeedBurner

FeedBurner FeedCount

Blog Archive